Blockchain Registration Transaction Record

Optimi Health Hails TGA Framework Expansion for Psychedelic Therapies

Optimi Health (OPTH) welcomes TGA's expanded framework for psilocybin and MDMA therapies, broadening access to psychedelic-assisted treatment for PTSD and depression in Australia.

This news matters because it signals a major regulatory shift that could make psychedelic-assisted therapy more accessible to patients suffering from PTSD and treatment-resistant depression. With no serious adverse events reported and an expanded framework, more psychiatrists can prescribe these treatments, potentially transforming mental healthcare in Australia and setting a precedent for other countries. For investors, it highlights Optimi Health's strategic position in a rapidly growing market.